PRESS RELEASE published on 11/17/2025 at 16:10, 10 months ago DigiKey to Highlight Innovative Automation Products and Industry-Leading Suppliers at SPS 2025 DigiKey showcases innovative automation products and top suppliers at SPS 2025, presenting a wide range of industrial automation solutions in Europe with interactive displays and expert insights Industrial Automation SPS 2025 DigiKey Automation Products Suppliers
PRESS RELEASE published on 11/17/2025 at 16:10, 10 months ago GPO Plus, Inc. Announces 20% Sequential Quarterly Revenue Growth and Accelerates Near-Term Expansion Initiatives GPO Plus, Inc. reports 20% revenue growth for Q2 2025, exceeding targets, expanding call center capacity, and accelerating store expansion with new product programs Revenue Growth Store Expansion GPO Plus Inc. Call Center Capacity New Product Programs
PRESS RELEASE published on 11/17/2025 at 16:05, 10 months ago SwitchBot Launches the New Presence Sensor with mmWave Radar SwitchBot officially launches the new Presence Sensor featuring mmWave radar for accurate room detection and smart automation, offering enhanced energy efficiency for homes Energy Efficiency Smart Home Automation SwitchBot Presence Sensor MmWave Radar
PRESS RELEASE published on 11/17/2025 at 15:37, 10 months ago Gold Terra is Upsizing Its Private Placement from C$6.3 Million to C$7.0 Million Gold Terra Resource Corp. announces oversubscription of non-brokered private placement with strong investor demand, total gross proceeds of C$7,000,000 and issuance of 55 million common shares and flow-through common shares Private Placement Flow-through Shares Investor Demand Gold Terra Yellowknife Project
PRESS RELEASE published on 11/17/2025 at 15:19, 10 months ago Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) with a BUY rating and USD 15.00 price target. Results show operational improvement and positive data on certepetide platform First Berlin Equity Research BUY Rating Research Update Lisata Therapeutics Inc Certepetide Platform
PRESS RELEASE published on 11/17/2025 at 15:14, 10 months ago Amundi Physical Metals plc: Final Terms Amundi Physical Metals plc issues Final Terms for ETC Securities of Amundi Physical Gold ETC under Secured Precious Metal Linked ETC Securities Programme Gold ETC Amundi Physical Metals Plc ETC Securities Final Terms Secured Precious Metal
PRESS RELEASE published on 11/17/2025 at 15:08, 10 months ago Amundi Physical Metals plc: UK Final Terms Amundi Physical Metals plc issues ETC Securities of Amundi Physical Gold ETC under its Secured Precious Metal Linked ETC Securities Programme. Details include Metal Entitlement and Issue Date Gold ETC Amundi Physical Metals Plc ETC Securities Precious Metal Tranche Issue
PRESS RELEASE published on 11/17/2025 at 14:32, 10 months ago Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG to Buy with a target price of EUR 1.10. Analysis includes H1 2025 results and future outlook First Berlin Equity Research Buy Recommendation Research Update Deutsche Effecten- Und Wechsel-Beteiligungsgesellschaft AG EUR 1.10 Target Price
PRESS RELEASE published on 11/17/2025 at 14:30, 10 months ago Kidoz Inc. to Publish Q3 2025 Financial Results on Thursday November 20th, 2025 Kidoz Inc. to publish Q3 earnings on ACCESS Newswire & websites. Annual General Meeting on Nov 25, 2025, in Vancouver & online. AdTech platform for safe mobile gamer engagement Annual General Meeting Kidoz Inc. Q3 Earnings AdTech Platform Mobile Gamer Engagement
PRESS RELEASE published on 11/17/2025 at 14:30, 10 months ago NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position NanoViricides, Inc. files Form 10-Q for Q3 2025 with SEC, presents NV-387 as broad-spectrum antiviral drug addressing unmet medical needs. Company strengthens financial position with recent financings NanoViricides NV-387 Financings Form 10-Q Antiviral Drug
Published on 09/17/2026 at 15:55, 5 hours 14 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 5 hours 44 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 6 hours 9 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 6 hours 9 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 19 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 2 hours 9 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 2 hours 11 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 2 hours 44 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 2 hours 59 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 23 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 3 hours 29 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 3 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 14 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification